ONWARD Medical: more grants are coming in to advance Parkinson's disease!
Along with the imminent kick-off of the US IDE study for ARC-IM targeting Blood Pressure (BP) in the SCI population, ONWARD Medical is advancing its ARC-IM pipeline in Parkinson’s disease within a financially de-risked setting launching two early feasibility studies to address i) mobility challenge
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.